On July 18, according to reports, OpenEvidence, a medical artificial intelligence startup known as the “Doctor's version of ChatGPT,” is preparing a new round of financing plans. According to reports, due to its strong performance in clinical decision support and medical data analysis, external venture capital institutions are issuing potential valuations of up to 20 billion US dollars and actively seeking shares.

On July 18, according to reports, OpenEvidence, a medical artificial intelligence startup known as the “Doctor's version of ChatGPT,” is preparing a new round of financing plans. According to reports, due to its strong performance in clinical decision support and medical data analysis, external venture capital institutions are issuing potential valuations of up to 20 billion US dollars and actively seeking shares.